AxioMx's Acquisition

AxioMx was acquired by Abcam on November 11, 2015.

AxioMx is a provider in recombinant antibody technologies. AxioMx's platform of phage display libraries, Rapid Liquid Screening, and affinity maturation methods enables fast delivery of highly specifi…

Articles about AxioMx's Acquisition: